RECRUITING

Working With Doctors and Pharmacists to Help Parents Give Children's Liquid Medicines Safely

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The study objective is to assess the impact of an automated electronic health record (EHR)-based intervention that leverages e-prescriptions to support pharmacist adherence to recommended dispensing practices, with the goal of reducing parent dosing errors. Specifically, the study aims are to: 1) Examine the efficacy of the EHR-based intervention in improving pharmacy dispensing practices, including a) adherence to mL-only dosing and b) provision of optimal dosing tools; 2) Examine the efficacy of the EHR-based intervention in reducing parent dosing errors. The study will also explore whether implementation of the EHR-based intervention will reduce disparities in dosing errors by parent health literacy and LEP, and explore the efficacy of the EHR-based intervention in reducing ADEs. A pre-/post-implementation study will be performed with English- and Spanish-speaking parents of children prescribed oral liquid medications in the pediatric emergency room, outpatient general pediatric clinic, and pediatric subspecialty clinics of 2 New York City hospital systems (NYU Langone Health - Brooklyn and NYC Health+Hospitals - Bellevue Hospital). Prior to implementation, e-Rx's will be generated by the EHR in the usual fashion; after implementation, e-Rx's will be generated by the EHR with instructions to the dispensing pharmacy to: 1) keep the dosing instructions in mL-only, and 2) dispense a specific dosing tool based on the amount prescribed. The proposed project is consistent with a growing national focus on promoting the adoption of evidence-based strategies to improve disease management that address the needs of those with low health literacy and LEP from groups like the Joint Commission and the AHRQ.

Official Title

Leveraging the EHR to Promote Pharmacy Adoption of Dosing Best Practices and Reduce Parent Errors in Administering Pediatric Liquid Medications: A Health Literacy-Informed Approach

Quick Facts

Study Start:2022-04-21
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05146388

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. English or Spanish-speaking
  2. 2. Parent or legal guardian of a child prescribed a liquid medicine in the NYU Langone Health - Brooklyn or Bellevue ED, general outpatient pediatric clinic, or specialty care clinics
  3. 3. 18 years of age or older
  4. 4. Child ≤8y discharged home with a Rx for ≥1 daily liquid medication dose ≤10mL, for use as a chronic or short course (≤14 days) medication
  5. 5. Primary person who will administer child's medications
  6. 6. Access to a smartphone that can take photos and send/receive text messages
  7. 7. Willingness and ability to participate
  8. 1. Works at a pharmacy that dispensed index medicine to one of our study participants.
  1. 1. Does not have a working phone number
  2. 2. Not able to return for in-person follow-up visit
  3. 3. Was told to stop medication by provider after doctor/ED visit
  4. 4. Parent no longer having index medication bottle
  5. 5. Uncorrected hearing impairment
  6. 6. Self-reported poor visual acuity
  7. 1. Staff with no responsibility in determining unit of measure to include on Rx's or type/capacity of the dosing tool to dispense for pediatric oral liquid medications.

Contacts and Locations

Study Contact

H. Shonna Yin, MD, MS
CONTACT
212-562-2821
Hsiang.Yin@nyulangone.org
Jennifer Melgar, MBS
CONTACT
212-562-2821
Jennifer.Melgar@nyulangone.org

Principal Investigator

H. Shonna Yin, MD, MS
PRINCIPAL_INVESTIGATOR
NYU Langone Health

Study Locations (Sites)

NYU Langone Health - Brooklyn
Brooklyn, New York, 11220
United States
Sunset Park Family Health Center at NYU Langone
Brooklyn, New York, 11220
United States
NYC Health + Hospitals / Bellevue
New York, New York, 10016
United States

Collaborators and Investigators

Sponsor: NYU Langone Health

  • H. Shonna Yin, MD, MS, PRINCIPAL_INVESTIGATOR, NYU Langone Health

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-21
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2022-04-21
Study Completion Date2024-12-31

Terms related to this study

Keywords Provided by Researchers

  • Electronic Prescriptions (e-Rx)
  • Pharmacy Dispensing Practices

Additional Relevant MeSH Terms

  • Medication Dosing Error